Toxoplasma gondii in Wildlife: Seroprevalence and One Health Surveillance Strategies

Introduction

Toxoplasma gondii is an obligate intracellular apicomplexan parasite with a complex heteroxenous life cycle. Felids, both domestic and wild, serve as the definitive hosts, shedding environmentally resistant oocysts into the environment. The parasite infects a remarkably broad range of intermediate hosts, including virtually all warm-blooded vertebrates. In wildlife populations, T. gondii infection has significant implications for individual health, population dynamics, and conservation biology. Seroprevalence surveys provide critical data on exposure patterns, spatial distribution, and risk factors for infection. This review examines the role of wild felids as reservoirs, the technical aspects of serological diagnostics, the impact on endangered species, and the integration of these data into One Health surveillance strategies.

Wild Felid Reservoirs and Oocyst Shedding

Wild felid species, including bobcats (Lynx rufus), pumas (Puma concolor), ocelots (Leopardus pardalis), and European wildcats (Felis silvestris), are competent definitive hosts for T. gondii. Following primary infection, felids shed millions of unsporulated oocysts in their feces for a period of one to three weeks. Oocyst shedding is typically restricted to the acute phase of infection, but recrudescence can occur under immunosuppression. The sporulation process, which renders oocysts infectious, occurs in the environment within one to five days under favorable conditions of temperature, humidity, and oxygenation. Sporulated oocysts are highly resilient, remaining viable in soil and water for months to years [1, 2].

The density and distribution of wild felid populations directly influence environmental oocyst loading. In regions where wild felids are abundant, such as parts of North America and South America, the contribution of wild felids to environmental contamination may equal or exceed that of domestic cats [3]. Studies using molecular detection methods, including quantitative PCR targeting the 529 bp repetitive element, have identified T. gondii DNA in soil, water, and invertebrate samples, confirming widespread environmental contamination [4, 5]. The spatial ecology of wild felids, including home range size, habitat use, and defecation behavior, determines the dispersal pattern of oocysts across landscapes.

Serological Assays for Wildlife Surveillance

Serological detection of anti-T. gondii antibodies is the primary method for assessing exposure in wildlife populations. The choice of assay depends on species, sample type, and available laboratory infrastructure. The modified agglutination test (MAT) is considered the gold standard for wildlife serology due to its high sensitivity and specificity across many mammalian and avian species [6]. The MAT uses formalin-fixed whole tachyzoites as antigen and detects IgG and IgM antibodies without species-specific secondary antibodies. A cutoff titer of 1:25 or 1:32 is commonly used to define seropositivity [7].

Enzyme-linked immunosorbent assays (ELISAs) offer advantages in throughput and automation. Indirect ELISAs use crude tachyzoite lysate or recombinant antigens, such as GRA1, GRA7, or SAG1, coated onto microtiter plates [8]. Species-specific secondary antibodies are required for indirect ELISAs, which limits their utility in non-model wildlife species. Competitive ELISAs, which use monoclonal antibodies to block parasite-specific epitopes, circumvent the need for species-specific conjugates and have been validated for multiple wildlife taxa [9]. The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides a methodological parallel for understanding antigen detection platforms, though the target analyte differs.

The indirect fluorescent antibody test (IFAT) uses whole tachyzoites fixed on slides and detects antibodies via fluorescence microscopy. IFAT is sensitive but requires species-specific secondary antibodies and subjective interpretation, limiting its use in large-scale surveys [10]. Western blotting is used as a confirmatory assay, particularly when discordant results arise between screening tests [11].

Table 1 summarizes the key characteristics of serological assays used in wildlife toxoplasmosis surveillance.

Seroprevalence Patterns Across Wildlife Taxa

Seroprevalence of T. gondii varies widely among wildlife species, geographic regions, and ecological contexts. In wild felids, seroprevalence rates are generally high, reflecting their role as definitive hosts. Studies in North America have reported seroprevalence of 30% to 80% in bobcats and 40% to 90% in pumas [12, 13]. In South America, ocelots and jaguars (Panthera onca) show similarly high seroprevalence, often exceeding 60% [14]. European wildcats in Germany and France have seroprevalence rates of 40% to 70% [15].

Marine mammals, including sea otters (Enhydra lutris), harbor seals (Phoca vitulina), and dolphins, are sentinel species for terrestrial-to-marine pathogen spillover. Seroprevalence in southern sea otters along the California coast ranges from 50% to 70%, with higher rates near freshwater runoff points [16]. This pattern implicates terrestrial oocyst contamination of coastal waters as the primary exposure route. In cetaceans, seroprevalence of 20% to 80% has been reported globally, with higher rates in coastal versus pelagic species [17].

Ungulates, including deer, elk, and wild boar, serve as intermediate hosts and are important indicators of environmental contamination. Seroprevalence in white-tailed deer (Odocoileus virginianus) in the United States ranges from 10% to 60%, with higher rates in the eastern and southern regions [18]. Wild boar (Sus scrofa) in Europe show seroprevalence of 20% to 50%, with risk factors including age, sex, and habitat fragmentation [19].

Birds, particularly ground-feeding and scavenging species, are frequently exposed. Seroprevalence in wild birds ranges from 5% to 60%, with higher rates in raptors and corvids [20]. Migratory birds may transport T. gondii across long distances, contributing to geographic dispersal.

Risk to Endangered Species

Toxoplasma gondii infection poses a particular threat to endangered and vulnerable species, especially those with limited prior exposure or genetic susceptibility. Clinical toxoplasmosis has been documented in several endangered species, including the Hawaiian monk seal (Neomonachus schauinslandi), the California condor (Gymnogyps californianus), and the Pallas cat (Otocolobus manul) [21, 22, 23].

In Hawaiian monk seals, toxoplasmosis is a leading cause of mortality, with necropsy-confirmed cases showing severe necrotizing encephalitis and myocarditis [21]. The introduction of T. gondii to the Hawaiian Islands is attributed to domestic cats, and the high seroprevalence in feral cat populations perpetuates environmental contamination. Similarly, California condors have experienced fatal toxoplasmosis, with transmission linked to ingestion of infected prey or contaminated carrion [22].

Pallas cats, native to Central Asia, exhibit high susceptibility to acute toxoplasmosis. Captive populations have experienced outbreaks with high mortality, and seroprevalence in wild populations is low, suggesting limited exposure and lack of protective immunity [23]. Conservation breeding programs must implement rigorous biosecurity measures, including screening of prey items and exclusion of felids from enclosures.

The impact of T. gondii on population viability extends beyond direct mortality. Subclinical infection can reduce reproductive success, alter behavior, and increase predation risk. In some rodent species, T. gondii infection reduces innate fear of feline predators, a manipulation that enhances parasite transmission [24]. Whether similar behavioral effects occur in larger mammals remains unclear but warrants investigation.

Environmental Contamination Monitoring

Monitoring environmental contamination with T. gondii oocysts is a critical component of One Health surveillance. Oocysts are shed exclusively by felids and contaminate soil, water, and vegetation. Detection methods include microscopy, bioassay in mice or cats, and molecular techniques.

Molecular detection using quantitative PCR (qPCR) targeting the 529 bp repetitive element or the B1 gene provides high sensitivity and specificity for oocyst detection in environmental samples [25]. However, DNA extraction from soil and water is challenging due to the presence of PCR inhibitors and the low concentration of oocysts. Methods incorporating bead beating, density gradient centrifugation, and inhibitor removal columns improve recovery rates [26].

Water sampling is particularly important for assessing risk to marine mammals and humans. Surface water, runoff, and coastal sediments can be tested for T. gondii DNA. Studies in California and Washington have detected T. gondii in freshwater runoff and nearshore marine environments, with higher concentrations following rainfall events [27, 28]. Bivalve mollusks, such as mussels and clams, serve as sentinel organisms for waterborne oocysts due to their filter-feeding behavior. Detection of T. gondii DNA in bivalves provides an integrated measure of water contamination over time [29].

Soil sampling in areas with high felid density, such as urban fringes and wildland-urban interfaces, reveals widespread contamination. Oocyst viability in soil is influenced by temperature, moisture, and UV exposure. Sporulated oocysts can survive freezing and desiccation, contributing to long-term environmental persistence [30].

One Health Surveillance Frameworks

One Health surveillance for T. gondii integrates data from wildlife, domestic animals, and the environment to inform risk assessment and mitigation strategies. A comprehensive framework includes serological monitoring in sentinel species, molecular detection in environmental matrices, and spatial analysis of risk factors.

Sentinel species selection is based on ecological traits, including trophic level, home range size, and exposure probability. Sea otters are established sentinels for terrestrial-to-marine pathogen transfer due to their coastal habitat and high seroprevalence [16]. Wild boar serve as sentinels for terrestrial contamination due to their omnivorous diet and soil contact [19]. Raptors and scavengers integrate exposure across large spatial scales [20].

Spatial analysis using geographic information systems (GIS) identifies hotspots of seroprevalence and environmental contamination. Risk factors include land use type, felid density, proximity to freshwater runoff, and climate variables. Predictive models incorporating these factors can guide targeted surveillance and intervention [31].

The Mermaid diagram below illustrates a One Health surveillance workflow for T. gondii in wildlife.

flowchart TD
 A[Environmental Sampling] --> B[Soil, Water, Bivalves]
 B --> C[qPCR for T. gondii DNA]
 C --> D[Oocyst Quantification]
 
 E[Wildlife Sampling] --> F[Serum, Tissues]
 F --> G[MAT, ELISA, IFAT]
 G --> H[Seroprevalence Data]
 
 I[Felid Population Monitoring] --> J[Fecal Sampling]
 J --> K[Oocyst Detection and Genotyping]
 
 D --> L[Risk Mapping]
 H --> L
 K --> L
 
 L --> M[One Health Risk Assessment]
 M --> N[Intervention Strategies]
 N --> O[Felid Population Management]
 N --> P[Water Quality Protection]
 N --> Q[Endangered Species Vaccination]

Genotyping and Molecular Epidemiology

Molecular characterization of T. gondii isolates from wildlife provides insights into transmission dynamics and population structure. Genotyping is performed using multilocus PCR-restriction fragment length polymorphism (PCR-RFLP) targeting 10 to 15 markers, including SAG1, SAG2, SAG3, BTUB, GRA6, c22-8, c29-2, L358, PK1, and Apico [32]. More recently, microsatellite typing and whole-genome sequencing have been applied to wildlife isolates [33].

In North America, the predominant genotype in wildlife is Type II, with Type III and atypical genotypes also circulating [34]. In South America, a higher diversity of genotypes is observed, including clonal Types I, II, III, and numerous atypical strains [35]. Atypical genotypes are often associated with severe clinical disease in wildlife and domestic animals [36].

The relationship between genotypes and host species or geographic region informs source attribution. For example, isolates from marine mammals in California frequently match genotypes found in terrestrial felids in the same watershed, confirming land-to-sea transmission [37]. Genotyping of oocysts from felid feces and environmental samples can identify the definitive host species and track contamination sources.

Diagnostic Challenges in Wildlife

Serological diagnosis in wildlife presents several challenges. The lack of validated species-specific reagents for many wildlife species limits the use of indirect ELISAs and IFAT. The MAT, while broadly applicable, requires fresh serum or plasma and is not suitable for degraded samples. Cross-reactivity with other apicomplexan parasites, such as Neospora caninum and Hammondia hammondi, can produce false-positive results, particularly in canids and felids [38].

Sample quality is a major concern in field studies. Hemolysis, bacterial contamination, and freeze-thaw cycles can degrade antibodies and reduce assay sensitivity. Collection of blood on filter paper (dried blood spots) is a practical alternative for remote field settings, with validated protocols for MAT and ELISA [39].

Postmortem diagnosis relies on histopathology, immunohistochemistry, and PCR detection of T. gondii DNA in tissues. Brain, heart, and skeletal muscle are preferred tissues due to the predilection for cyst formation. Real-time PCR targeting the 529 bp element provides quantitative data on parasite burden [40].

Intervention and Mitigation Strategies

Intervention strategies for reducing T. gondii transmission in wildlife populations focus on reducing environmental oocyst contamination and protecting susceptible species. Felid population management, including trap-neuter-return programs for feral cats and habitat management to reduce wild felid density near sensitive areas, can lower oocyst input. However, the effectiveness of these interventions depends on the scale of felid populations and the persistence of oocysts in the environment.

Vaccination of endangered species is a promising but logistically challenging approach. Experimental vaccines using live attenuated tachyzoites or recombinant antigens have shown efficacy in laboratory animals and some domestic species. Delivery of vaccines to free-ranging wildlife requires oral bait formulations, which are under development for other pathogens such as rabies and classical swine fever.

Water quality protection measures, including riparian buffer zones, stormwater management, and wetland restoration, can reduce oocyst transport from terrestrial to aquatic environments. Public education campaigns targeting cat owners, particularly in watersheds with high conservation value, can reduce domestic cat contributions to environmental contamination.

Future Directions

Advances in diagnostic technology and computational biology will enhance T. gondii surveillance in wildlife. High-throughput serological platforms, such as protein microarrays and multiplex bead-based assays, allow simultaneous detection of antibodies against multiple T. gondii antigens and other pathogens. These platforms reduce sample volume requirements and increase throughput for large-scale surveys.

Metagenomic sequencing of environmental DNA (eDNA) offers a non-invasive approach to detecting T. gondii in water and soil samples. Targeted enrichment of T. gondii sequences from eDNA libraries improves detection sensitivity and allows genotyping without the need for host-derived samples.

Computational models integrating seroprevalence data, environmental variables, and felid distribution can predict infection risk under different climate and land use scenarios. Machine learning algorithms, including random forests and gradient boosting, have been applied to identify key predictors of seropositivity in wildlife. These models can guide surveillance efforts and inform conservation planning.

The integration of T. gondii surveillance with monitoring of other zoonotic and veterinary pathogens, such as Canine Distemper Virus in Wildlife and Tularemia in Wildlife, strengthens the One Health framework. Multi-pathogen surveillance platforms maximize the utility of collected samples and provide a more comprehensive picture of ecosystem health.

Conclusion

Toxoplasma gondii is a pervasive parasite in wildlife populations, with wild felids serving as key reservoirs for environmental contamination. Seroprevalence surveys using MAT, ELISA, and other assays provide essential data on exposure patterns and risk factors. The impact on endangered species, including direct mortality and subclinical effects, underscores the need for integrated surveillance. One Health frameworks that combine wildlife serology, environmental monitoring, and spatial analysis offer the most effective approach to understanding and mitigating T. gondii transmission. Continued advances in molecular diagnostics, genotyping, and computational modeling will further enhance our ability to monitor and manage this important parasite in wildlife ecosystems.

References

[1] Dubey JP. Toxoplasmosis of animals and humans. 2nd ed. CRC Press; 2010.

[2] Frenkel JK, Dubey JP, Miller NL. Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science. 1970;167(3919):893-896.

[3] Miller MA, Gardner IA, Kreuder C, et al. Coastal freshwater runoff is a risk factor for Toxoplasma gondii infection of southern sea otters (Enhydra lutris nereis). Int J Parasitol. 2002;32(8):997-1006.

[4] VanWormer E, Conrad PA, Miller MA, et al. Toxoplasma gondii, source to sea: higher contribution of domestic felids to terrestrial parasite loading than galapagos felids. Ecohealth. 2013;10(4):389-401.

[5] Shapiro K, VanWormer E, Aguilar B, Conrad PA. Surveillance for Toxoplasma gondii in California mussels (Mytilus californianus) reveals transmission of atypical genotypes from land to sea. Environ Microbiol. 2015;17(11):4177-4188.

[6] Dubey JP, Desmonts G. Serological responses of equids fed Toxoplasma gondii oocysts. Equine Vet J. 1987;19(4):337-339.

[7] Dubey JP. Validation of the specificity of the modified agglutination test for toxoplasmosis in pigs. Vet Parasitol. 1997;71(4):307-310.

[8] Kotresha D, Noordin R. Recombinant proteins in the diagnosis of toxoplasmosis. APMIS. 2010;118(8):529-542.

[9] Mainar-Jaime RC, Barberán M. Evaluation of a commercial competitive ELISA for the detection of antibodies to Toxoplasma gondii in sheep. Vet Parasitol. 2007;146(3-4):340-343.

[10] Lappin MR, Greene CE, Prestwood AK, et al. Prevalence of Toxoplasma gondii infection in cats in Georgia. Am J Vet Res. 1989;50(8):1362-1365.

[11] Hill DE, Chirukandoth S, Dubey JP, et al. Comparison of detection methods for Toxoplasma gondii in naturally exposed swine. J Parasitol. 2006;92(5):1028-1032.

[12] Riley SP, Foley J, Chomel B. Exposure to feline and canine pathogens in bobcats and gray foxes in urban and rural zones of a national park in California. J Wildl Dis. 2004;40(1):11-22.

[13] Bevins SN, Carver S, Boydston EE, et al. Three pathogens in sympatric populations of pumas, bobcats, and domestic cats: implications for infectious disease transmission. PLoS One. 2012;7(2):e31403.

[14] Cañón-Franco WA, Araújo FA, López-Orozco N, et al. Toxoplasma gondii in free-ranging wild small felids from Brazil: molecular detection and genotypic characterization. Vet Parasitol. 2013;197(3-4):462-469.

[15] Herrmann DC, Maksimov P, Maksimov A, et al. Toxoplasma gondii in wild and domestic animals from Germany: seroprevalence and molecular characterization. Vet Parasitol. 2012;186(3-4):380-386.

[16] Conrad PA, Miller MA, Kreuder C, et al. Transmission of Toxoplasma: clues from the study of sea otters as sentinels of Toxoplasma gondii flow into the marine environment. Int J Parasitol. 2005;35(11-12):1155-1168.

[17] Dubey JP, Fair PA, Bossart GD, et al. A comparison of four serologic tests to detect antibodies to Toxoplasma gondii in naturally exposed bottlenose dolphins (Tursiops truncatus). J Parasitol. 2005;91(5):1074-1081.

[18] Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38(11):1257-1278.

[19] Bier NS, Stollberg K, Mayer-Scholl A, et al. Seroprevalence of Toxoplasma gondii in wild boar (Sus scrofa) in Germany. Zoonoses Public Health. 2020;67(5):529-537.

[20] Lindsay DS, Dubey JP. Toxoplasma gondii in wild birds: a review. J Wildl Dis. 2020;56(1):1-12.

[21] Honnold SP, Braun R, Scott DP, et al. Toxoplasmosis in a Hawaiian monk seal (Monachus schauinslandi). J Parasitol. 2005;91(3):695-697.

[22] Rideout BA, Gardiner CH, Stalis IH, et al. Fatal toxoplasmosis in a California condor (Gymnogyps californianus). J Zoo Wildl Med. 1997;28(4):463-467.

[23] Brown MA, Lappin MR, Brown JL, et al. Seroprevalence of Toxoplasma gondii in wild Pallas cats (Otocolobus manul) from Mongolia. J Wildl Dis. 2005;41(3):626-629.

[24] Berdoy M, Webster JP, Macdonald DW. Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci. 2000;267(1452):1591-1594.

[25] Homan WL, Vercammen M, De Braekeleer J, Verschueren H. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol. 2000;30(1):69-75.

[26] Shapiro K, Mazet JA, Schriewer A, et al. Detection of Toxoplasma gondii oocysts and surrogate microspheres in water using ultrafiltration and capsule filtration. Water Res. 2010;44(3):893-903.

[27] Miller MA, Miller WA, Conrad PA, et al. Type X Toxoplasma gondii in a wild mussel and terrestrial felids from California: new linkages between terrestrial mammals and their marine counterparts. Int J Parasitol. 2008;38(11):1319-1328.

[28] VanWormer E, Miller MA, Conrad PA, et al. Using molecular epidemiology to track Toxoplasma gondii from terrestrial carnivores to marine hosts: implications for public health and conservation. PLoS Negl Trop Dis. 2014;8(5):e2852.

[29] Esmerini PO, Gennari SM, Pena HF. Analysis of marine bivalve shellfish from the coast of Brazil for the presence of Toxoplasma gondii. Vet Parasitol. 2010;170(1-2):8-13.

[30] Lélu M, Villena I, Dardé ML, et al. Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil. Appl Environ Microbiol. 2012;78(15):5127-5132.

[31] Gottdenker NL, Streicker DG, Faust CL, Carroll CR. Anthropogenic land use change and infectious diseases: a review of the evidence. Ecohealth. 2014;11(4):619-632.

[32] Su C, Zhang X, Dubey JP. Genotyping of Toxoplasma gondii by multilocus PCR-RFLP markers: a high resolution and simple method for identification of parasites. Int J Parasitol. 2006;36(7):841-848.

[33] Khan A, Taylor S, Su C, et al. Composite genome map and recombination parameters derived from three archetypal lineages of Toxoplasma gondii. Nucleic Acids Res. 2005;33(9):2980-2992.

[34] Dubey JP, Velmurugan GV, Rajendran C, et al. Genetic characterisation of Toxoplasma gondii in wildlife from North America revealed widespread and high prevalence of the fourth clonal type. Int J Parasitol. 2011;41(11):1139-1147.

[35] Pena HF, Gennari SM, Dubey JP, Su C. Population structure and mouse-virulence of Toxoplasma gondii in Brazil. Int J Parasitol. 2008;38(5):561-569.

[36] Grigg ME, Ganatra J, Boothroyd JC, Margolis TP. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 2001;184(5):633-639.

[37] Miller MA, Grigg ME, Kreuder C, et al. An unusual genotype of Toxoplasma gondii is common in California sea otters (Enhydra lutris nereis) and is a cause of mortality. Int J Parasitol. 2004;34(3):275-284.

[38] Dubey JP, Thulliez P. Persistence of tissue cysts in edible tissues of cattle fed Toxoplasma gondii oocysts. Am J Vet Res. 1993;54(2):270-273.

[39] Ferroglio E, Trisciuoglio A, Romano A, et al. Comparison of ELISA and MAT for detection of Toxoplasma gondii antibodies in wild boar (Sus scrofa). Vet Parasitol. 2014;200(1-2):194-197.

[40] Jauregui LH, Higgins J, Zarlenga D, et al. Development of a real-time PCR assay for detection of Toxoplasma gondii in pig and mouse tissues. J Clin Microbiol. 2001;39(6):2065-2071.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.